Annual report pursuant to Section 13 and 15(d)

SCHEDULE OF ACCRUED EXPENSES (Details)

v3.22.4
SCHEDULE OF ACCRUED EXPENSES (Details) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Payables and Accruals [Abstract]    
Accrued pre-clinical and clinical costs $ 2,137,317 $ 5,435,464
Accrued product development costs 247,500 203,676
Accrued compensation 2,224,951 2,715,368
Accrued administrative costs 473,376 1,213,699
Accrued interest 916,108 525,105
Total $ 5,999,252 $ 10,093,312